Annual Operating Expenses
$33.41 M
+$3.01 M+9.90%
December 31, 2022
Summary
- As of February 8, 2025, VBLT annual total operating expenses is $33.41 million, with the most recent change of +$3.01 million (+9.90%) on December 31, 2022.
- During the last 3 years, VBLT annual operating expenses has risen by +$12.98 million (+63.58%).
Performance
VBLT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$327.00 K
-$2.97 M-90.08%
June 30, 2023
Summary
- As of February 8, 2025, VBLT quarterly total operating expenses is $327.00 thousand, with the most recent change of -$2.97 million (-90.08%) on June 30, 2023.
- Over the past year, VBLT quarterly operating expenses has dropped by -$9.32 million (-96.61%).
Performance
VBLT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
VBLT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.9% | -96.6% |
| 3 y3 years | +63.6% | -94.5% |
| 5 y5 years | +38.2% | -92.3% |
VBLT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -9.0% | -96.9% | at low |
| 5 y | 5-year | at high | -38.9% | -96.9% | at low |
| alltime | all time | at high | -62.7% | -96.9% | at low |
Vascular Biogenics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $327.00 K(-90.1%) |
| Mar 2023 | - | $3.29 M(-4.4%) |
| Dec 2022 | $33.41 M(+9.9%) | $3.45 M(-64.4%) |
| Sep 2022 | - | $9.69 M(+0.5%) |
| Jun 2022 | - | $9.64 M(-9.2%) |
| Mar 2022 | - | $10.62 M(+15.3%) |
| Dec 2021 | $30.40 M(+21.5%) | $9.21 M(+39.1%) |
| Sep 2021 | - | $6.62 M(-18.5%) |
| Jun 2021 | - | $8.12 M(+26.1%) |
| Mar 2021 | - | $6.44 M(-11.5%) |
| Dec 2020 | $25.01 M(+22.5%) | $7.28 M(+23.7%) |
| Sep 2020 | - | $5.88 M(-2.0%) |
| Jun 2020 | - | $6.00 M(+2.6%) |
| Mar 2020 | - | $5.85 M(-1.2%) |
| Dec 2019 | $20.42 M(-5.3%) | $5.92 M(+17.8%) |
| Sep 2019 | - | $5.03 M(+2.4%) |
| Jun 2019 | - | $4.91 M(+7.6%) |
| Mar 2019 | - | $4.56 M(+7.7%) |
| Dec 2018 | $21.57 M | $4.24 M(-25.6%) |
| Sep 2018 | - | $5.69 M(+33.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $4.25 M(-42.4%) |
| Mar 2018 | - | $7.39 M(+0.6%) |
| Dec 2017 | $24.18 M(+48.6%) | $7.35 M(+13.4%) |
| Sep 2017 | - | $6.48 M(+26.8%) |
| Jun 2017 | - | $5.11 M(-2.7%) |
| Mar 2017 | - | $5.25 M(+9.0%) |
| Dec 2016 | $16.27 M(+9.4%) | $4.82 M(+45.8%) |
| Sep 2016 | - | $3.30 M(+0.4%) |
| Jun 2016 | - | $3.29 M(-32.4%) |
| Mar 2016 | - | $4.87 M(+52.8%) |
| Dec 2015 | $14.87 M(+0.6%) | $3.18 M(-44.5%) |
| Sep 2015 | - | $5.74 M(+83.6%) |
| Jun 2015 | - | $3.12 M(+10.4%) |
| Mar 2015 | - | $2.83 M(-43.7%) |
| Dec 2014 | $14.78 M(-7.4%) | $5.02 M(+48.2%) |
| Sep 2014 | - | $3.39 M(-1.5%) |
| Jun 2014 | - | $3.44 M(+17.7%) |
| Mar 2014 | - | $2.92 M(-39.1%) |
| Dec 2013 | $15.96 M(+28.0%) | $4.80 M(+28.4%) |
| Sep 2013 | - | $3.74 M |
| Dec 2012 | $12.47 M | - |
FAQ
- What is Vascular Biogenics annual total operating expenses?
- What is the all time high annual operating expenses for Vascular Biogenics?
- What is Vascular Biogenics annual operating expenses year-on-year change?
- What is Vascular Biogenics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Vascular Biogenics?
- What is Vascular Biogenics quarterly operating expenses year-on-year change?
What is Vascular Biogenics annual total operating expenses?
The current annual operating expenses of VBLT is $33.41 M
What is the all time high annual operating expenses for Vascular Biogenics?
Vascular Biogenics all-time high annual total operating expenses is $33.41 M
What is Vascular Biogenics annual operating expenses year-on-year change?
Over the past year, VBLT annual total operating expenses has changed by +$3.01 M (+9.90%)
What is Vascular Biogenics quarterly total operating expenses?
The current quarterly operating expenses of VBLT is $327.00 K
What is the all time high quarterly operating expenses for Vascular Biogenics?
Vascular Biogenics all-time high quarterly total operating expenses is $10.62 M
What is Vascular Biogenics quarterly operating expenses year-on-year change?
Over the past year, VBLT quarterly total operating expenses has changed by -$9.32 M (-96.61%)